EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
April 29, 2024 07:00 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., April 29, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of positive long-term results and subgroup analyses from the...
Meningococcal Vaccines Market to hit USD 7.8 Bn by 2032, says Global Market Insights Inc.
April 29, 2024 04:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, April 29, 2024 (GLOBE NEWSWIRE) -- Meningococcal Vaccines Market Size will reach USD 7.8 billion by 2032, cites the latest report by Global Market Insights Inc. According to...
Drug Delivery Technologies market is projected to grow at a CAGR of 5.5% by 2034: Visiongain
April 26, 2024 09:15 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Drug Delivery Technologies Market Report 2024-2034: Forecasts by Route of Administration (Implantable Drug Delivery, Injectable Drug Delivery Nasal Drug...
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
April 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 25, 2024 (GLOBE NEWSWIRE) -- Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche,...
American Kidney Fund Launches National Kidney Health Equity Media Campaign
April 25, 2024 09:01 ET
|
American Kidney Fund
ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- As part of its longstanding commitment to kidney health equity, the American Kidney Fund (AKF) has launched a national media campaign aimed at...
Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
April 25, 2024 08:50 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18
April 25, 2024 08:45 ET
|
International Myeloma Foundation
On April 18, the International Myeloma Foundation held its 15th Annual Gala at the Edison Ballroom for the first time in New York, hosted by Ray Romano.
Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research
April 25, 2024 08:33 ET
|
Polaris Market Research & Consulting LLP
New York, NY, April 25, 2024 (GLOBE NEWSWIRE) -- According to Polaris Market Research, the global acute repetitive seizures market size and share was valued at USD 2.90 billion in 2023 and is...
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
April 25, 2024 07:00 ET
|
Regeneron Pharmaceuticals, Inc.
Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types Mammoth to...
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
April 25, 2024 07:00 ET
|
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts John Davis brings direct clinical expertise as...